Modern trends in the radiological diagnostics of adrenal tumors
Problems of Endocrinology · 07.03.2026 · 72 (1) · 8-12
DOI: 10.14341/probl13733 ↗Kurz gefasst
Editorial in der Zeitschrift Problems of Endocrinology, online erschienen am 07.03.2026. Verfasst von N G Mokrysheva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Research Centre. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Tomography, X-Ray Computed. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Russian Ministry of Health.
Abstract (Originalsprache)
The editorial examines modern trends and new technologies in the radiological diagnostics of adrenal tumors, such as dual-energy computed tomography and textural analysis methods utilizing machine learning. Particular attention is paid to the differential diagnosis of adrenal masses, including multi‑class differentiation. Research data demonstrating the high diagnostic efficacy of these approaches are presented, and the importance of an interdisciplinary and personalized approach in patient management is emphasized. The material reflects current achievements and future prospects for the development of radiological methods in endocrinology and oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Endocrinology Research Centre.
Förderung
- Russian Ministry of Health
Zitieren
APA
Mokrysheva, N. G., & Tarbaeva, N. V. (2026). Modern trends in the radiological diagnostics of adrenal tumors. Problems of Endocrinology, 72(1), 8-12. https://doi.org/10.14341/probl13733
Vancouver
Mokrysheva NG, Tarbaeva NV. Modern trends in the radiological diagnostics of adrenal tumors. Problems of Endocrinology. 2026;72(1):8-12. doi:10.14341/probl13733
BibTeX
@article{Mokrysheva2026,
author = {Mokrysheva, N G and Tarbaeva, N V},
title = {Modern trends in the radiological diagnostics of adrenal tumors},
journal = {Problems of Endocrinology},
year = {2026},
volume = {72},
number = {1},
pages = {8--12},
doi = {10.14341/probl13733}
}
EUVIMED